Blood Glucose Monitoring Devices Market

By Product;

Self-Monitoring Devices (Blood Glucose Meter, Testing Strips and Lancets), Continuous Blood Glucose Monitoring Devices (Sensors, Transmitter & Receiver and Lancets)

By Modality;

Invasive and Non-Invasive

By Indication;

Diabetes Type I, Diabetes Type II and Gestational Diabetes

By End-Use;

Hospitals, Home Care and Diagnostic Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn674066890 Published Date: June, 2025 Updated Date: August, 2025

Blood Glucose Monitoring Devices Market Overview

Blood Glucose Monitoring Devices Market (USD Million)

Blood Glucose Monitoring Devices Market was valued at USD 16,645.87 million in the year 2024. The size of this market is expected to increase to USD 28,713.51 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.1%.


Blood Glucose Monitoring Devices Market

*Market size in USD million

CAGR 8.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)8.1 %
Market Size (2024)USD 16,645.87 Million
Market Size (2031)USD 28,713.51 Million
Market ConcentrationMedium
Report Pages400
16,645.87
2024
28,713.51
2031

Major Players

  • Medtronic plc
  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Lifescan, Inc.
  • B. Braun Melsungen AG,
  • Dexcom, Inc.
  • Sanofi
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Intuity Medical

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Blood Glucose Monitoring Devices Market

Fragmented - Highly competitive market without dominant players


The Blood Glucose Monitoring Devices Market is driven by major technological advancements, with more than 60% of development dedicated to continuous and wearable glucose sensors. These innovations improve efficacy, enabling real-time tracking and reducing invasive tests. Improved monitoring reliability is generating steady growth and building confidence among users.

Integration-Focused Cooperation Boosts Care Delivery
Nearly 50% of product initiatives result from collaboration and partnerships among device makers, healthcare IT companies, and care providers. These strategies ensure seamless data interoperability, telehealth connectivity, and regulatory compliance. Interconnected solutions support widespread expansion of digital diabetes management.

Consolidations Driving Scale and Support Quality
Close to 35% of market progression is linked to merger activities that combine device innovators with analytics platforms and fulfillment networks. These integrations enhance technological capabilities, expand manufacturing capacity, and streamline after-sales service. The merged infrastructure promotes extensive expansion of monitoring ecosystems.

AI-Enabled Dashboards Delivering Actionable Management
With over 50% of patients and clinicians using AI-powered apps and dashboards, blood glucose data is now more insightful than ever. These tools enable trend prediction, alert notifications, and personalized guidance. The blend of digital analytics with device function showcases key technological advancements, enabling sustained growth and a proactive future outlook in diabetes therapy.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Modality
    3. Market Snapshot, By Indication
    4. Market Snapshot, By End-use
    5. Market Snapshot, By Region
  4. Blood Glucose Monitoring Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increase in sedentary lifestyles
        2. Rising obesity rates
        3. Demand for minimally invasive devices
        4. Enhanced diagnostic accuracy
      2. Restraints
        1. Resistance to new technologies
        2. Strict regulatory requirements
        3. Risk of device-related infections
      3. Opportunities
        1. Opportunities in wearable technology
        2. Expansion of home healthcare services
        3. Promotion of diabetes education programs
        4. Expansion of e-commerce platforms
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Blood Glucose Monitoring Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Self-monitoring Devices
        1. Lancets
        2. Testing Strips
        3. Blood Glucose Meter
      2. Continuous Blood Glucose monitoring devices
        1. Sensors
        2. Transmitter & Receiver
        3. Lancets
    2. Blood Glucose Monitoring Devices Market, By Modality, 2021 - 2031 (USD Million)
      1. Invasive
      2. Non-Invasive
    3. Blood Glucose Monitoring Devices Market, By Indication, 2021 - 2031 (USD Million)
      1. Diabetes Type I
      2. Diabetes Type II
      3. Gestational Diabetes
    4. Blood Glucose Monitoring Devices Market, By End-use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Home Care
      3. Diagnostic Centers
    5. Blood Glucose Monitoring Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Medtronic plc
      2. F. Hoffmann-La Roche Ltd
      3. Bayer AG
      4. Lifescan, Inc.
      5. B. Braun Melsungen AG,
      6. Dexcom, Inc.
      7. Sanofi
      8. Abbott Laboratories
      9. Ascensia Diabetes Care Holdings AG
      10. Intuity Medical
  7. Analyst Views
  8. Future Outlook of the Market